Chlamydia Diagnostics Market - Market - Positive Long-Term Growth Outlook 2029

Chlamydia is one of the most widespread sexually transmitted diseases. It is caused by bacteria named Chlamydomonas trachomatis. This disease is more common in females as compared to male population. In addition, the disease is more prevalent in people who are older than 25 years due to multiple sex and sex partners. In 2011, around 1,412,791 people were suffering from Chlamydia in the U.S. Chlamydia is a silent infection and shows negligible symptoms such as abnormal vaginal discharge, pain while sex, painful urination, clear discharge from the tip of penis. In addition, it also results in abdominal pain, swellings around testicles, burning around vagina.

The clinically evident symptoms compel the patients to undergo various diagnostic tests which include Nucleic Acid Amplification Tests (NAAT), direct immunofluorescence, cell culture, Enzyme Immunoassay (EIA) and nucleic acid hybridization. NAAT amongst all is the most sensitive test for detection of Chlamydomonas trachomatis in urine and vaginal swab. It has been approved by FDA for its detection in sample like urine and vaginal swab. In EIA diagnostic tests, (Immunoglobulin G) IgG is significantly used and is capable of detecting the presence of C. trachomatis however in direct immunofluorescence, monoclonal antibodies are used. The nucleic acid hybridization helps in detecting the DNA sequence of the bacteria and thus results in detecting C. trachomatis.

Browse Global Strategic Business Report:
http://www.transparencymarketresearch.com/chlamydia-diagnostics-market.html

Change in lifestyle has resulted in multiple sex and sex partner. It has been observed that one out of three people suffer from chlamydia every year and it is expected to rise drastically. This significant rise of Chlamydia patients worldwide would augment the growth of this market. Chlamydia increases the risk of HIV infection and this is raising serious concerns for the governments across the globe. The U.S. government has been promoting and educating people about Chlamydia infections. In addition, they have also launched various programs for safe and healthy sex. Moreover, according to Common Health Committee, governments of various nations are increasing their funding for diagnostic tests. This would trigger the growth of this market.

Some of the major players in chlamydia diagnostic market include Abbott Laboratories, Bio-Rad, Novartis Diagnostics, Roche, Wallac, ID Biomedical and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments

Download Exclusive Brochure of This Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1533

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.